Treatment of postmenopausal osteoporosis patients with teriparatide for 24 months reverts forming bone quality indices to premenopausal healthy control values
Autor: | Paschalis, Eleftherios P., Gamsjaeger, Sonja, Klaushofer, Klaus, Shane, Elizabeth, Cohen, Adi, Stepan, Jan, Pavo, Imre, Eriksen, Erik F., Taylor, Kathleen A., Dempster, David W. |
---|---|
Zdroj: | In Bone September 2022 162 |
Databáze: | ScienceDirect |
Externí odkaz: |